Canada proposes new submission type for emergency-use drugs
This article was originally published in SRA
Executive Summary
The Canadian Department of Health has proposed amendments to its regulations on emergency-use drugs, such as anthrax and pandemic influenza vaccines, to create a new type of drug submission that would subject these products to comprehensive pre-market review and enhanced post-market surveillance1,2.